Adaptive study of treatments for staph bloodstream infection
Treatments studied
Part of Infections clinical trials.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your blood culture grew Staphylococcus aureus, found in at least one blood test
- You were admitted to a participating hospital when the study checks your eligibility
- They can start study track planning within 72 hours of your first positive blood culture
- Your infection is not a mixed (“polymicrobial”) blood infection with multiple bacteria (except contaminants)
- You haven’t already joined this same randomized SNAP platform before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether adding ertapenem to cefazolin can improve treatment of staphylococcus (“S. aureus”) bloodstream infection that is likely methicillin-susceptible (MSSA). It aims to start the right antibiotics quickly, before MRSA status is fully confirmed, using early testing and a treatment plan guided by infectious-disease specialists.
This trial tests whether giving two antibiotics early, instead of the usual one, improves recovery for people with a staph bloodstream infection (a serious bacterial infection in the blood). If you qualify, participation will involve close monitoring and follow-up care.
This study tests a simpler way to explain the trial and get your consent. If you have a staph bloodstream infection, you may be able to join and help improve how consent is done for future patients.
This trial compares two antibiotics, vancomycin and daptomycin, to see which works better for treating MRSA bacteria in the blood. Patients are randomly assigned to one of the drugs and will be monitored closely for results and side effects.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial tests whether adding clopidogrel, a blood thinner, to standard care can help treat staph bloodstream infections. It may reduce the risk of complications, but it is only for patients who can take oral medications and are not at high risk of bleeding.
Hear when a new Staphylococcus Aureus Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.